{
  "guideline": {
    "id": "PA166265421",
    "name": "Annotation of DPWG Guideline for quetiapine and CYP3A4",
    "source": "DPWG",
    "version": 8,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166265421",
    "relatedChemicals": [
      {
        "id": "PA451201",
        "name": "quetiapine",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA130",
        "name": "cytochrome P450 family 3 subfamily A member 4",
        "symbol": "CYP3A4"
      }
    ],
    "recommendation": true,
    "guidelineGenes": [
      {
        "alleles": [
          {
            "id": 1451778541,
            "_label": "*1",
            "function": {
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335"
            }
          },
          {
            "id": 1451723460,
            "_label": "*6",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451723434,
            "_label": "*8",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723441,
            "_label": "*11",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723435,
            "_label": "*12",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723436,
            "_label": "*13",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723437,
            "_label": "*16",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723438,
            "_label": "*17",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723442,
            "_label": "*18",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723443,
            "_label": "*20",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451723439,
            "_label": "*22",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451723444,
            "_label": "*26",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451778542,
            "_label": "*36",
            "function": {
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335"
            }
          }
        ],
        "gene": {
          "chr": {
            "id": "PA534",
            "name": "chr7",
            "symbol": null
          },
          "strand": "minus",
          "id": "PA130",
          "name": "cytochrome P450 family 3 subfamily A member 4",
          "symbol": "CYP3A4"
        }
      }
    ]
  },
  "annotationGroups": [
    {
      "id": "PA166267021",
      "name": "Intermediate Metabolizer",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP3A4:Decreased function/Normal function",
        "CYP3A4:No function/Normal function"
      ],
      "metabolizerStatus": {
        "id": 1451901341,
        "html": "<p>Intermediate Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451901342,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": {
        "id": 1451901340,
        "html": "<p>This gene variation reduces the conversion of quetiapine to inactive metabolites and a metabolite with anti-depressant effect. However, the effect on the plasma concentration\nof quetiapine is limited (20% increase) and it is not known whether this has any clinical consequences. The relationship between the plasma concentration and clinical effect is\nweak for quetiapine.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166267041",
      "name": "Poor Metabolizer",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Yes",
        "termId": "rxChange:1448602497"
      },
      "genePhenotypes": [
        "CYP3A4:Decreased function/Decreased function",
        "CYP3A4:Decreased function/No function",
        "CYP3A4:No function/No function"
      ],
      "metabolizerStatus": {
        "id": 1451901344,
        "html": "<p>Poor Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451901345,
        "html": "<p>Indication DEPRESSION: Choose an alternative. Aripiprazole appears to be less dependent of CYP3A4 for metabolism. Olanzapine is not metabolised by CYP3A4.<br />\n&nbsp;<br />\nOTHER INDICATIONS: Use 30% of the standard dose.</p>\n"
      },
      "implications": {
        "id": 1451901343,
        "html": "<p>The plasma concentration of quetiapine is 3.2-fold higher in these patients. In addition, the formation of the active metabolite N-desalkylquetiapine, which is probably\nresponsible for the antidepressant effect, should be reduced. The gene variation results in reduced activity of the enzyme CYP3A4, which converts quetiapine to N-desalkylquetiapine\nand an inactive metabolite.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166267061",
      "name": "Normal Metabolizer",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP3A4:Normal function/Normal function"
      ],
      "metabolizerStatus": {
        "id": 1451901361,
        "html": "<p>Normal Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451901362,
        "html": "<p>The guideline does not provide a recommendation for quetiapine in normal metabolizers.</p>\n"
      },
      "implications": {
        "id": 1451901360,
        "html": "<p>The guideline does not provide a description of the impact of a normal metabolizer phenotype on quetiapine.</p>\n"
      },
      "activityScore": null
    }
  ],
  "citations": [],
  "version": "2023-01-05-00-25"
}